Volume 27, Number 8—August 2021
Research
Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo
Figure 2

Figure 2. Diagnostic algorithm applied after a negative malaria test, persistent fever after malaria treatment, or symptoms suggestive of human African trypanosomiasis, Democratic Republic of the Congo. LGP, Lymph gland puncture; LP, lumbar puncture; mAECT, mini anion exchange centrifugation test; NEXT, nifurtimox/eflornithine combination therapy; RDT, rapid diagnostic test.
1Deceased.
Page created: June 10, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.